Balyasny Asset Management
KIN

Balyasny Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Balyasny Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-482,563
Closed -$4.43M – 2286
2021
Q2 		$4.43M Buy
+482,563
New +$4.43M 0.02% 671